#VisualAbstract Adding a novel inflammatory marker to a scoring tool better predicted mortality in patients with epidermal necrolysis byKathleen Lau December 30, 2021 0
#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate byKathleen Lau January 15, 2021 0
